4.7 Article

Synthesis and biological evaluation of new 13-n-nonylprotoberberine derivatives as antitubercular agents

Journal

ACTA PHARMACEUTICA SINICA B
Volume 3, Issue 1, Pages 38-45

Publisher

INST MATERIA MEDICA, CHINESE ACAD MEDICAL SCIENCES
DOI: 10.1016/j.apsb.2012.12.004

Keywords

13-n-nonylberberine; Antitubercular; Structure-activity relationship; MIC; Drug-resistant

Funding

  1. National Natural Science Fund for Young Scientists [81102312]
  2. National S&T Major Special Project on Major New Drug Innovation [2012ZX09301002-001]

Ask authors/readers for more resources

Tuberculosis is a serious threat to public health throughout the world. A series of new 13-n-nonylprotoberberine derivatives was designed, synthesized and evaluated for anti-mycobacterial activity against Mycobacterium tuberculosis strain H(37)Rv. Several compounds (2, 11a-c, 11g, 13d, 15c) exhibited excellent anti-tubercular activity with an MIC below 1.0 mu g/mL. Notably, compound 13d showed potential antibacterial effect against both drug-susceptible and multidrug-resistant (MDR) M. tuberculosis with MIC ranges of 0.0625-1.0 mu g/mL. These results suggest a mode of action different from that of the current anti-mycobacterial drugs rifampicin and isoniazid. Hence, compound 13d is an attractive lead compound for the development of new antitubercular agents. (C) 2013 Institute of Materia Medica, Chinese Academy of Medical Sciences and Chinese Pharmaceutical Association. Production and hosting by Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available